应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
NTGN Neon Therapeutics Inc.
停牌 05-05 16:00:00 EDT
3.07
+0.00
0.00%
最高
3.07
最低
3.07
成交量
0.00
今开
3.07
昨收
3.07
日振幅
0.00%
总市值
8,893万
流通市值
4,665万
总股本
2,897万
成交额
0.00
换手率
0.00%
流通股本
1,520万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称:
Neon Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Neon Therapeutics, Inc.于2013年10月根据特拉华州法律注册成立,其名称为Onco3,Inc.。Neon Therapeutics,Inc.是一家临床阶段免疫肿瘤学公司,也是新抗原领域的领导者,目标疗法,致力于通过将免疫系统导向新抗原来改变癌症的治疗。基因突变是癌症的一个标志,可导致称为新抗原的特异性免疫靶标。癌细胞中新抗原的存在及其在正常细胞中的缺乏使得它们成为癌症治疗的引人注目的未开发靶标。
发行价格:
--
{"stockData":{"symbol":"NTGN","market":"US","secType":"STK","nameCN":"Neon Therapeutics Inc.","latestPrice":3.07,"timestamp":1588708800000,"preClose":3.07,"halted":3,"volume":0,"delay":0,"floatShares":15196186,"shares":28966658,"eps":-2.681502,"marketStatus":"停牌","marketStatusCode":0,"change":0,"latestTime":"05-05 16:00:00 EDT","open":3.07,"high":3.07,"low":3.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.681502,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724054400000},"adr":0,"listingDate":1530072000000,"adjPreClose":3.07,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/NTGN","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.neontherapeutics.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.04},{"period":"1month","weight":-0.0047},{"period":"3month","weight":0.047},{"period":"6month","weight":0.1097},{"period":"1year","weight":0.2705},{"period":"ytd","weight":0.1662}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neon Therapeutics, Inc.于2013年10月根据特拉华州法律注册成立,其名称为Onco3,Inc.。Neon Therapeutics,Inc.是一家临床阶段免疫肿瘤学公司,也是新抗原领域的领导者,目标疗法,致力于通过将免疫系统导向新抗原来改变癌症的治疗。基因突变是癌症的一个标志,可导致称为新抗原的特异性免疫靶标。癌细胞中新抗原的存在及其在正常细胞中的缺乏使得它们成为癌症治疗的引人注目的未开发靶标。","exchange":"NASDAQ","name":"Neon Therapeutics Inc.","nameEN":"Neon Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neon Therapeutics Inc.(NTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neon Therapeutics Inc.(NTGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neon Therapeutics Inc.,NTGN,Neon Therapeutics Inc.股票,Neon Therapeutics Inc.股票老虎,Neon Therapeutics Inc.股票老虎国际,Neon Therapeutics Inc.行情,Neon Therapeutics Inc.股票行情,Neon Therapeutics Inc.股价,Neon Therapeutics Inc.股市,Neon Therapeutics Inc.股票价格,Neon Therapeutics Inc.股票交易,Neon Therapeutics Inc.股票购买,Neon Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neon Therapeutics Inc.(NTGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neon Therapeutics Inc.(NTGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}